Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MN

Mark C. Noe — 15 Patents

Pfizer: 16 patents #230 of 5,153Top 5%
OPOsi Pharmaceuticals: 2 patents #70 of 181Top 40%
Mystic, CT: #19 of 230 inventorsTop 9%
Connecticut: #2,943 of 34,797 inventorsTop 9%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Mark C. Noe has been granted 15 US patents while listed as an inventor at Pfizer. The first was granted in 2001 and the most recent in September 2010. Mark C. Noe ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Mark C. Noe in Mystic, CT, US.

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
7790902 Isothiazole derivatives useful as anticancer agents Eric R. Larson, Thomas G. Gant 2010-09-07 $201,585,000
7462600 Macrolides Louis S. Chupak, Mark E. Flanagan, Takushi Kaneko, Thomas Victor Magee, Usa Reilly 2008-12-09 $305,764,000
7405218 Isothiazole derivatives useful as anticancer agents Eric R. Larson, Thomas G. Gant 2008-07-29
7030242 Selective inhibition of aggrecanase in osteoarthritis treatment Michael A. Letavic, Louis S. Chupak, Kim F. McClure 2006-04-18 $147,716,000
6919332 N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors Lilli Ann Wolf-Gouveia 2005-07-19 $201,677,000
6916807 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors Kevin Daniel Freeman-Cook 2005-07-12 $283,397,000
6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors Kevin Daniel Freeman-Cook 2005-05-31 $186,252,000
6841671 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors Martin James Wythes, Brian Bronk 2005-01-11 $947,451,000
6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors Lawrence Alan Reiter, Martin James Wythes 2004-03-16 $212,687,000
6608104 Gem substituted hydroxamic acids 2003-08-19 $165,603,000
6599890 Arylsulfonyl hydroxamic acid derivatives Kim F. McClure, Michael A. Letavic, Louis S. Chupak 2003-07-29 $490,376,000
6548526 Isothiazole derivatives useful as anticancer agents Eric R. Larson, Thomas G. Gant 2003-04-15 $153,685,000
6380214 Heterocyclic derivatives useful as anticancer agents Thomas G. Gant 2002-04-30 $143,968,000
6329397 Hydroxy pipecolate hydroxamic acid derivatives Kim F. McClure, Michael A. Letavic, Louis S. Chupak 2001-12-11 $347,021,000
6235764 Isothiazole derivatives useful as anticancer agents Eric R. Larson, Thomas G. Gant 2001-05-22 $476,743,000